Hannah Jörißen

Title: Innovations and Contributions of Inventor Hannah Jörißen

Introduction

Hannah Jörißen is a notable inventor based in Heiligenhaus, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of five patents to her name, her work has the potential to impact various therapeutic areas.

Latest Patents

Among her latest patents is the invention of Anti-A2AP antibodies and their uses. This invention relates to an isolated antibody or antigen-binding fragment that binds to human A2AP. The isolated antibody is characterized by its ability to cross-react with rabbit and/or cynomolgus A2AP, not inhibiting human plasmin activity, and enhancing plasmin-mediated clot lysis in the presence of A2AP. Another significant patent involves antibodies capable of binding to the coagulation factor XIa. This invention focuses on methods of use for these antibodies as agents that inhibit platelet aggregation, thereby preventing thrombus formation.

Career Highlights

Hannah has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. Her experience in these organizations has contributed to her expertise in the development of innovative therapeutic solutions.

Collaborations

Hannah has collaborated with several professionals in her field, including colleagues Andreas Wilmen and Julia Straßburger. These collaborations have likely enriched her research and development efforts.

Conclusion

Hannah Jörißen's contributions to the field of biotechnology through her innovative patents and collaborations highlight her role as a significant inventor. Her work continues to pave the way for advancements in medical treatments and therapies.